Şunu aradınız:: pharmaceutica (İngilizce - Maltaca)

pharmaceutica l form
għamla farmaċewtika

janssen pharmaceutica n. v.
janssen pharmaceutica n. v.

janssen pharmaceutica nv turnhoutseweg 30
janssen pharmaceutica nv, turnhoutseweg 30

luxembourg/luxemburg glaxosmithkline pharmaceutica belgique/belgien
luxembourg/luxemburg glaxosmithkline pharmaceuticals s.a./n.v.

janssen pharmaceutica nv, turnhoutseweg 30, 2340 beerse, belgium
janssen pharmaceutica nv, turnhoutseweg 30, 2340 beerse, il-belġju

janssen pharmaceutica nv turnhoutseweg 30 b-2340 beerse, belgium
janssen pharmaceutica nv turnhoutseweg 30 b- 2340 beerse, belgium

janssen pharmaceutica nv, turnhoutseweg 30, b-2340 beerse, belgium
janssen pharmaceutica nv, turnhoutseweg 30, b-2340 beerse, il-belġju

name and address of the manufacturer responsible for batch release janssen pharmaceutica nv
isem u indirizz tal-manifattur responsabbli għall-ħruġ tal-lott janssen pharmaceutica nv

janssen-pharmaceutica n. v., turnhoutseweg 30, b-2340 beerse, belgium.
janssen- pharmaceutica n. v., turnhoutseweg 30, b- 2340 beerse, belgium

manufacturer: janssen pharmaceutica nv, turnhoutseweg 30, b-2340 beerse, belgium.
manifattur: janssen pharmaceutica nv, turnhoutseweg 30, b-2340 beerse, il-belġju.

the european commission granted a marketing authorisation valid throughout the european union, for meloxivet to janssen pharmaceutica n. v. on 14 november 2007 information on the prescription status of this product may be found on the label of the carton.
l- informazzjoni dwar l- istat tal- preskrizzjoni ta ’ dan il- prodott tista ’ jinstab fuq it- tikketta ta ’ dan il- pakkett.

in column 2 of the annex to regulation (ec) no 162/2003 the words ‘janssen pharmaceutica nv’ are replaced by ‘eli lilly and company ltd’.
fil-kolonna 2 tal-anness tar-regolament (ke) nru 162/2003, il-kelmiet “janssen pharmaceutica nv” jinbidlu bil-kelmiet “eli lilly and company ltd.”.